0001140361-15-021768.txt : 20150526
0001140361-15-021768.hdr.sgml : 20150525
20150526195224
ACCESSION NUMBER: 0001140361-15-021768
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150526
FILED AS OF DATE: 20150526
DATE AS OF CHANGE: 20150526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajer Jeffrey Robert
CENTRAL INDEX KEY: 0001557533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 15890724
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2015-05-26
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001557533
Ajer Jeffrey Robert
C/O BIOMARIN PHARMACEUTICAL INC.,
770 LINDARO ST.
SAN RAFAEL
CA
94901
0
1
0
0
SVP, Chief Commercial Of
Common Stock
2015-05-26
2015-05-26
4
S
0
1625
126.5523
D
39245
D
Trade made pursuant to a 10b5-1 plan executed May 11, 2015.
The price in column 4 is a weighted average price. The price actually received ranged from $125.64 to $128.47. The reporting person shall provide to the issuer, and security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2015-05-26